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Abstract
Background: Fatigue is one of the most commonly reported symptoms of multiple sclerosis (MS). It has a profound impact on
all spheres of life, for people with MS and their relatives. It is one of the key precipitants of early retirement. Individual, group,
and Internet cognitive behavioral therapy–based approaches to supporting people with MS to manage their fatigue have been
shown to be effective.
Objective: The aim of this project was to (1) survey the types of mobile devices and level of Internet access people with MS
use or would consider using for a health intervention and (2) characterize the levels of fatigue severity and their impact experienced
by the people in our sample to provide an estimate of fatigue severity of people with MS in New Zealand. The ultimate goal of
this work was to support the future development of a mobile intervention for the management of fatigue for people with MS.
Methods: Survey methodology using an online questionnaire was used to assess people with MS. A total of 51 people with MS
participated. The average age was 48.5 years, and the large majority of the sample (77%) was female.
Results: Participants reported significant levels of fatigue as measured with the summary score of the Neurological Fatigue
Index (mean 31.4 [SD 5.3]). Most (84%) respondents scored on average more than 3 on the fatigue severity questions, reflecting
significant fatigue. Mobile phone usage was high with 86% of respondents reporting having a mobile phone; apps were used by
75% of respondents. Most participants (92%) accessed the Internet from home.
Conclusions: New Zealand respondents with MS experienced high levels of both fatigue severity and fatigue impact. The
majority of participants have a mobile device and access to the Internet. These findings, along with limited access to face-to-face
cognitive behavioral therapy–based interventions, create an opportunity to develop a mobile technology platform for delivering
a cognitive behavioral therapy–based intervention to decrease the severity and impact of fatigue in people with MS.
(JMIR Mhealth Uhealth 2017;5(2):e6)   doi:10.2196/mhealth.6192
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Introduction
New Zealand has a high prevalence of multiple sclerosis (MS).
In 2006, the age-standardized prevalence of MS among the
general population of New Zealand was 71.9 per 100,000 [1].
In contrast, the age-standardized prevalence of MS in Māori
has remained constant at 17.5 per 100,000 [1]. Between 1968
and 2006, the disease frequency for MS in New Zealand has
increased by nearly 90%, from 37.8 in 1968 to current level of
71.9 [2]. During the same 38-year period, the gender ratio
essentially remained constant.
One of the most commonly reported symptoms of MS is fatigue,
affecting more than 80% of patients [3]. Although often
identified as a symptom of MS, fatigue is often not treated,
perhaps because it typically appears unrelated to the severity of
the central disease process [4]. MS fatigue differs from tiredness
experienced by healthy people in both severity and impact. MS
fatigue has a profound effect on all spheres of life [3,5] for
people with MS, their relatives, and the nursing staff [6,7].
Fatigue is one of the key precipitants of early retirement [8,9].
Little is known about levels of fatigue severity and the impact
experienced by people with MS fatigue in New Zealand [10].
Self-report measures of fatigue can be an appropriate assessment
option given the subjective experience of the symptom. The
advantage of self-report measures are that they are generally
short, widely available, easy for the patient to understand, and
require little training by the assessor [11]. Additionally,
self-report measures of fatigue have concurrent validity and are
acceptable to people with MS [12]. There is, however, large
variation and inconsistency across studies measuring the severity
and impact of MS fatigue, which might be partly due to different
measures used [13-16]).
At present, the range of measurement options means assessors
need to be clear about the aspects of fatigue they intend to
measure (eg, severity or impact of fatigue), in which population
and for what purpose, in order to select the most relevant
self-report measure. There is a paucity of research regarding
which measure of fatigue is the most appropriate under differing
conditions. A more concise definition of fatigue is needed, along
with a high-quality measurement instrument. To attempt to
address these issues for people with MS, the Neurological
Fatigue Index for MS was developed [16]. This scale was
designed to conform to the Rasch measurement model [17] and
rigorously tested to determine its reproducibility. The scale can
be used with people with MS of “any age, sex, and duration (of
MS symptoms)” [18]. The minimum clinically important
difference for the Neurological Fatigue Index for MS was found
to be small (2.49 of a 30-point range), such that changes in the
physical, cognitive, summary, and nocturnal sleep scales were
aligned with the respondents’ perceived changes in fatigue, and
most importantly, the resultant scores showed no change when
none was perceived [18].
The 13-item, self-report measure Fatigue Symptom Inventory
was originally designed to measure the intensity and duration
of fatigue and its interference with quality of life in breast cancer
patients [19]. Although the Fatigue Symptom Inventory has not
been validated for MS, Hann et al [19] suggest that the Fatigue
Symptom Inventory could be used to evaluate the physical and
psychological characteristics of fatigue and quality of life across
groups of patients with different diagnoses, and it has been used
extensively in research with MS patients.
Along with challenges in measuring severity and impact of MS
fatigue and the lack of New Zealand data, there have been
challenges in terms of delivering interventions for this group
of people. Cognitive behavioral therapy interventions for MS
fatigue, delivered in individual, group, or Internet programs,
have been found to be effective [20-25]. However, cognitive
behavioral therapy interventions delivered face-to-face are not
readily available due to the lack of people with this training
working in MS-related services and limited health resources
[10].
In New Zealand, a recent survey suggests 86% of people use
the Internet, of whom 91% have access to broadband [26]. A
key limitation of Internet-based cognitive behavioral therapy
programs for MS fatigue is that the person needs to be in front
of a computer. However, the number of people using
smartphones that have access to the Internet is increasing [26],
providing a fruitful opportunity for health applications. The key
advantages of mobile phone technologies include the ability to
provide an individual level of support to change health behaviors
and improve disease management, allowing temporal
synchronization of the intervention delivery and allowing the
intervention to claim people’s attention when it is most relevant
or in the best context [27]. There is increasing evidence that
text messages and other smartphone technology are effective
in drug adherence, improved diabetes self-management [28],
and cessation of smoking interventions [29]. However, other
than wearable sensors including accelerometers, gyroscopes,
and pressure-sensitive textiles [30], there is limited evidence
for the use of smartphone technology in people with MS [31-33].
The aim of the current project was to survey people with MS
to (1) review the types of mobile devices people with MS use
or would consider using for a health intervention, (2) identify
the level of Internet access they have, and (3) characterize the
levels of fatigue severity and their impact experienced by the
people in our sample to provide an estimate of fatigue severity
of people with MS in New Zealand. The ultimate goal of this
work was to guide the future development of a mobile
intervention for the management of fatigue for people with MS.
Methods
Questionnaire
A positivist paradigm theoretical framework and survey
methodology using a questionnaire was used. The questionnaire
included the following:
1. Collection of basic demographic data to enable the
contextualization of the data and duplicate checking
2. Assessment of fatigue severity measured using the
Neurological Fatigue Index for MS [16]
3. Assessment of fatigue impact measured with the Fatigue
Symptom Inventory, a 13-item self-report measure designed to
JMIR Mhealth Uhealth 2017 | vol. 5 | iss. 2 | e6 | p.2http://mhealth.jmir.org/2017/2/e6/
(page number not for citation purposes)
Van Kessel et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
assess the severity, frequency, and daily pattern of fatigue, as
well as its perceived interference with quality of life [34]
4. Questions on mobile phone and Internet usage derived from
the New Zealand World Internet Project [26] (approval for this
use was obtained)
Recruitment
People with MS were initially contacted via email by the
Multiple Sclerosis Society of New Zealand. The study used
Dillman’s [35] tailored survey design, which has been shown
to result in high response rates. It was not assumed that
participants had access to the Internet. A link to a website was
provided in the email, where participants could either complete
the survey online, request a call from the researcher to carry out
the survey by telephone, request a hard copy of the survey that
they returned by post, or request an electronic copy of the form
by email.
Statistical Analysis
All analysis was undertaken using SPSS Statistics (2015, IBM
Corp) software. The questionnaire data were analyzed as
follows:
1. Basic demographic data were checked for duplicate form
submissions. We planned to exclude any duplicate
questionnaires from the analysis.
2. Fatigue severity was calculated by summing relevant items
of the Neurological Fatigue Index for MS summary, physical,
diurnal sleep, nocturnal sleep, and cognitive scales. The raw
ordinal data were converted to interval-level data using the
conversion table set out by Mills and colleagues [16].
Descriptive statistics (means, SDs, ranges) were then calculated.
3. Fatigue impact, as measured by the Fatigue Symptom
Inventory, was analyzed descriptively (median, interquartile
range, range) for the following subscales: most severe fatigue,
least severe fatigue, average fatigue, present fatigue, and fatigue
interference with daily life activities.
4. Internet and mobile phone usage was analyzed using
frequencies and cross-tabulations by key demographic variables
(age, gender, area, and ethnicity).
Ethics Approval
Ethics approval for the study was obtained from the Auckland
University of Technology Ethics Committee (approval number
15/99).
Results
In total, 51 people with MS took part in the study. We cannot
comment on the response rate as recruitment was via social
media. The mean age of the participants was 48.5 (SD 12.8)
years and ranged from 26 to 71 years. A large majority (39/51,
77%) were female, 16% (8/51) were male, and the majority
were New Zealand European. The demographic distribution of
the respondents is shown in Table 1. Of the 51 respondents, 38
(75%) lived within an urban environment.
Findings of the levels of fatigue severity and their impact
experienced by participants are shown in Table 2. On average,
people suffered from significant levels of fatigue as measured
with the summary score of the Neurological Fatigue Index (mean
31.4, SD 5.3, range 15-40; maximum possible score is 40). The
highest fatigue scores were in the physical subcategory.
The Fatigue Symptom Inventory [24,34] is designed to assess
the severity, frequency, and daily pattern of fatigue as well as
its perceived interference with quality of life (see Table 3).
Table 1. Demographic characteristics of participants (N=51).
Characteristics
48.5 (12.8)Age (years), mean (SD)
26-71Range of cohort (years)
Gender, n (%)
39 (77)Female
8 (16)Male
4 (8)Missing data
Ethnicity, n (%)
39 (77)New Zealand European
7 (14)European
1 (2)Australian
4 (4)Missing data
Employment, n (%)
14 (28)Full-time
7 (14)Part-time
24 (47)Not employed
6 (12)Missing data
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Table 2. Descriptive statistics of the Neurological Fatigue Index (n=47).
MaximumMinimumSDMeanSubscale
32.010.04.725.8Physical
16.04.02.811.1Cognitive
23.011.02.716.7Relief by diurnal sleep or rest
20.09.02.814.6Abnormal sleep and sleepiness
40.015.05.331.4Summary
Table 3. Descriptive statistics of the Fatigue Symptom Inventory (n=47).
Mean (SD)
Fatigue severity in past week
7.06 (1.87)Maximum fatigue in past week
3.28 (1.87)Minimum fatigue in past week
5.09 (1.90)Average fatigue in past week
5.19 (2.48)Fatigue right now
5.15 (1.74)Subtotal
Fatigue interference with activities in past week
5.28 (2.65)General activity
2.38 (3.00)Ability to bathe and dress yourself
4.72 (2.95)Normal work activity
4.43 (2.88)Ability to concentrate
3.81 (2.54)Relations with other people
5.26 (2.62)Enjoyment of life
4.72 (3.01)Mood
4.37 (2.29)Subtotal
Frequency of fatigue in the past week
5.72 (1.81)Number of days fatigued in past week
5.45 (2.48)How much of the day were you fatigued
5.59 (2.14)Subtotal
Lower scores denote less acute problems with fatigue. The total
mean score of fatigue severity in the past week was 5.59 (SD
1.9). In total, 84% (43/51) of respondents scored on average
more than 3 on the fatigue severity questions, implying
significant fatigue. The total mean score for fatigue interference
with activities during the past week was 4.37 (SD 2.3). Fatigue
frequency during the past week was 5.45 (SD 2.5). The majority
of participants reported their fatigue to be worst in the afternoon
(22/51, 43%), but a sizeable group said there was no consistent
pattern to their fatigue (14/51, 28%). The majority of participants
(37/51, 73%) reported the use of strategies to alleviate fatigue
(eg, timing of certain activities, managing stress, pacing and
resting).
Mobile phone usage was high, with 86% (44/51) of respondents
reporting that they have a mobile phone; 41% (44/51) use an
iPhone, 39% (20/51) use an Android phone, 2% (1/51) use a
Windows phone, and 4% (2/51) use a Blackberry. In addition,
9% (5/51) have access to 2 phones.
Mobile phone apps were used by 75% (38/51) of respondents.
A total of 6% (3/51) stated they didn’t know, and 20% (10/51)
did not answer the question. Along with mobile phones, people
with MS reported using a range of other mobile devices,
including laptops (32/51, 63%) and tablets like iPad (25/51,
49%), iPod Touch (6/51, 12%), iPad Mini 4 of 51 (4/51, 8%),
and e-book readers (14/51, 28%). Half of respondents (25/51,
49%) had access to 2 mobile devices. Finally, 1 participant
could not afford a tablet and 1 person reported having no need
for one.
When asked where they were able to access the Internet, 92%
(47/51) reported accessing the Internet from home. Other
locations where participants accessed the Internet included work,
locations outside the home, and other homes (Table 4). Daily
Internet usage was commonly reported by participants with an
average use of 2 hours, 23 minutes per day. One-quarter (13/51,
26%) of participants did not access the Internet at all.
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Table 4. Locations where participants have Internet access.
PercentageLocation
92Home
33Work
2School
4Internet café
16Other homes
6Library
Some participants reported that mobile phone or app use was
negatively affected by their symptoms, such as visual problems
(6/51, 12%) and weakness (15/51, 29%). Examples of visual
problems included trouble focusing, optic neuritis, and blind
spots. People also reported other symptoms of MS that could
affect their use of such technology, such as eyestrain, general
fatigue, numbness in the fingers, numbness of 1 side of the body,
excessive tremor in hands and fingers, and 1 person reporting
difficulty with voice recognition training problematic because
of slurred speech.
Only a small percentage of participants (4/51, 8%) reported the
use of special devices to access mobile technology. Such special
devices included onscreen virtual keyboards (12/51, 23%),
alternative mouse systems (3/51, 6%), voice recognition (3/51,
6%), and a screen magnifier (2/51, 4%).
In summary, New Zealand survey participants with MS reported
high levels of both fatigue severity and fatigue impact.
Responses also indicated that the large majority of participants
have a mobile device, use apps, and have access to the Internet.
Discussion
Principal Findings
This study assessed levels of fatigue severity and their impact
experienced by people with MS in New Zealand. Fatigue
severity was measured using the Neurological Fatigue Index
for MS. Fatigue significantly affected nearly all of those who
took part in the study; both physical and cognitive fatigue
affected their quality of life. Of the subscale categories surveyed,
fatigue predominantly affected motor function and sleep
patterns, findings which are in line with the studies of Thomas
et al [23] and Carnicka et al [36]. Difficulties with motor
function and sleep often lead to anxiety and depression
[5,23,36,37]. Disruption of melatonin circadian rhythm
production and lower waking cortisol levels have been linked
with higher disability and fatigue scores in MS patients [38,39].
The majority of participants in this study experienced more
fatigue in the afternoon. This is consistent with subjective reports
of increasing cognitive fatigue during the day by MS patients
[40].
On the Fatigue Symptom Inventory, the majority (43/51, 84%)
of respondents reported this to be severe. Such levels of fatigue
interfered significantly with people’s day-to-day activities,
results that are consistent with those of Mills and Young [41],
who also found relationships between fatigue and disability,
disease type, and sleep.
Given that both fatigue severity and fatigue impact were reported
to be severe and significant, there is an important need for
accessible evidence-based interventions for people with MS.
The possibility of using mobile technology to deliver such an
intervention could be a solution to the current health
environment of scarce resources because people with MS appear
to be open to smartphone use in health care and have reported
many potential benefits [33,42]. This study obtained some useful
findings in regard to access and use of mobile technologies by
people with MS fatigue. The majority of participants in this
survey were open to smartphone use, and only a small number
of participants (2/51, 4%) reported MS symptoms that restricted
their use of mobile phone apps. Furthermore, most repondents
in the study had a mobile phone and access to the Internet at
home, suggesting that a sufficient platform exists to develop a
mobile app to deliver a cognitive behavioral therapy–based
intervention for MS fatigue.
The use of mobile technology in providing an intervention for
MS fatigue would need to consider MS disabilities which may
limit dexterity, and the design and implementation of eHealth
apps should be tailored to the patients’ individual needs [43].
There are a number of general benefits associated with mobile
technologies [44], which are also relevant to the population of
interest. The application of inexpensive wireless technologies
such as accelerometers and gyroscopes combined with
Internet-based or smartphone apps offers researchers and
clinicians a viable method of monitoring patients with MS. Such
feedback and biofeedback could improve self-management and
home-based rehabilitation [30,45]. Mobile technologies can
lower the costs and burden of travel to clinic-based assessments,
remove the subjectivity of self-reporting, and improve the
capture of data with greater accuracy and precision regarding
the daily impairment, disability, and functioning of patients
with MS [30,45]. Mobile technology also permits accessing
interventions at times of the day when the user is least affected
by fatigue [40].
Limitations and Future Directions
With such a small survey (51 respondents) and unknown
response rate it is difficult to ascertain conclusively the nature
and severity of symptoms of MS fatigue or the use of mobile
devices. However, the sample is reflective of the typical
epidemiology of people with MS (eg, predominantly female
and white). The findings of the study will be used to investigate
the benefits of a mobile technology app to deliver a cognitive
behavioral therapy–based intervention for the management of
MS fatigue.
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Conclusion
This survey has demonstrated that New Zealand respondents
with MS experienced high levels of both fatigue severity and
fatigue impact. The majority of participants have a mobile device
and access to the Internet. These factors, along with limited
access to face-to-face cognitive behavioral therapy–based
interventions, create an opportunity to develop a mobile
technology platform for delivering a cognitive behavioral
therapy–based intervention to improve the severity and impact
of fatigue in people with MS.
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